Bio Medica Laboratories Limited has successfully commenced its Initial Public Offering (IPO), which includes a fresh issue and an offer for sale by the selling shareholders, amounting to a total of ₹52.43 crore. The IPO process was guided by Legacy Law Offices, which provided comprehensive legal counsel to Bio Medica Laboratories, the selling shareholders Mr. Mukesh Mehta and Mr. Pradeep Mehta, and the Book Running Lead Manager, Narnolia Financial Services Ltd.
The legal team at Legacy Law Offices was spearheaded by Partner Pradyun Chakravarty and Counsel Naman Anand, with valuable support from Associates Meghna Shukla and Pallash Pamnani. Their expertise was instrumental in ensuring the smooth execution of this significant financial endeavor.
About Bio Medica Laboratories
Bio Medica Laboratories is a notable player in the pharmaceutical industry, specializing in the production of pharmaceutical parenteral formulations. The company offers a diverse range of products, including ethical drugs, generic drugs, and over-the-counter (OTC) medications, primarily in the form of injectables such as liquid injections and dry powder injections.
As part of our annual IPO coverage, we provide insights into the legal firms representing issuers and bankers in the 2024-25 period, a detailed report on which firms led the ₹1,000+ crore segment, and an analysis of the role of foreign law firms in Indian IPOs. Additionally, we explore the fee structures of law firms involved in IPOs.
If you are interested in having your deals, columns, or press releases published on Bar & Bench, please complete the submission form available here.
